CATABASIS PHARMACEUTICALS IN's ticker is CATB and the CUSIP is 14875P107. A total of 36 filers reported holding CATABASIS PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $4,000 | -20.0% | 5,000 | -0.1% | 0.00% | – |
| Q2 2018 | $5,000 | -44.4% | 5,006 | +0.1% | 0.00% | – |
| Q1 2018 | $9,000 | -43.8% | 5,000 | -33.3% | 0.00% | – |
| Q3 2017 | $16,000 | +700.0% | 7,500 | +650.0% | 0.00% | – |
| Q1 2017 | $2,000 | – | 1,000 | +3025.0% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 32 | -97.9% | 0.00% | – |
| Q2 2016 | $6,000 | +500.0% | 1,492 | +1281.5% | 0.00% | – |
| Q4 2015 | $1,000 | -83.3% | 108 | -85.3% | 0.00% | – |
| Q3 2015 | $6,000 | – | 736 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,857,667 | $22,661,000 | 18.22% |
| Clarus Ventures, LLC | 2,752,488 | $21,827,000 | 15.30% |
| Camber Capital Management LP | 1,000,000 | $7,930,000 | 0.51% |
| Rhenman & Partners Asset Management AB | 306,227 | $2,428,000 | 0.37% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 643,580 | $5,104,000 | 0.21% |
| SPHERA FUNDS MANAGEMENT LTD. | 80,742 | $640,000 | 0.09% |
| Spark Investment Management LLC | 23,100 | $183,000 | 0.02% |
| FRED ALGER MANAGEMENT, LLC | 157,782 | $1,251,000 | 0.01% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 45,000 | $357,000 | 0.01% |
| FEDERATED HERMES, INC. | 80,000 | $634,000 | 0.00% |